Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1991-03-06
1992-11-17
Nucker, Christine M.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
435 795, 435 793, 435 792, 436501, C12Q 100, G01N 3353, G01N 33566
Patent
active
051642956
ABSTRACT:
A method for identifying compounds useful for treating patients with amyloidosis is disclosed. Compounds are screened according to the present invention to determine their ability to modulate the affinity between amyloid protein and proteins of the extracellular matrix.
REFERENCES:
patent: 4666829 (1987-05-01), Glenner et al.
patent: 4956347 (1990-09-01), Ban et al.
patent: 4958347 (1990-09-01), Ban et al.
Perlmutter et al. (1990) Brian Research 508:13-19.
Young et al. (1989) Acta Neuropathol 78:202-209.
Perlmutter et al. (1990) Brian Res. Bull. 24:677-686.
Narindrasorasak et al. (1991) Abstract Only J Biol Chem 266:12878-83.
Perlmutter et al. (1990) Manl. Abstract Only Brain Res Bul 2415 677-686.
Perlmutter et al. (1990 Jan.) Abstract Only Neurology 5084 13-19.
Kang, J. et al., "The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor," 1987, Nature, 325: 733-736.
Ponte, P. et al., "A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors," 1988, Nature, 331: 525-527.
Kitaguchi, N et al., "Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity," 1988, Nature, 331: 530-532.
Selkoe, D. J., "Deciphering Alzheimer's disease: The amyloid precursor protein yields new clues," 1990, Science, 248: 1058-1060.
Wurtman, R. J., "Alzheimer's Disease," Scientific American, 252: 62-74.
Glenner, G. G., "The pathobiology of Alzheimer's disease," 1989, Ann. Rev. Med., 40: 45-51.
Muller-Hill, B., "Molecular biology of Alzheimer's disease," 1989, Annu. Rev. Biochem., 58: 287-307.
Price, D. L. et al., "Cellular and molecular biology of Alzheimer's disease," 1989, BioEssays, 10: 69-74.
Snow, A. D. et al., "The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease," 1988, American Journal of Pathology, 133: 456-463.
Snow, A. D. and Robert Kisilevsky, "Temporal relationship between glycosaminoglycan accumulation and amyloid deposition during experimental amyloidosis," 1985, Laboratory Investigation, 53: 37-44.
Snow, A. D. et al., "A close ultrastructural relationship between sulfated proteoglycans and AA amyloid fibrils," 1987, Laboratory Investigation, 57: 687-698.
Snow, A. D. et al., "Cationic dyes reveal proteoglycans structurally integrated within the characteristic lesions of Alzheimer's disease," 1989, Acta Neuropathol., 78: 113-123.
Young, I. D. et al., "The ultrastructural localization of sulfated proteoglycans is identical in the amyloids of Alzheimer's disease and AA, AL, senile cardiac and medullary carcinoma-associated amyloidosis," 1989, Acta Neuropathol., 78: 202-209.
Snow, A. D. et al., "Sulfated glycosamioglycans: A common constituent of all amyloids?" 1987, Laboratory Investigation, 56: 120-123.
McCubbin, W. D. et al., "Circular-dichroism studies on two murine serum amyloid A proteins," 1988, Biochem. J., 256: 775-783.
Norling, B. et al., "Immunohistochemical identification of heparan sulphate proteoglycan in secondary systemic amyloidosis," 1988, Clin. Exp. Immunol., 73: 333-337.
Kisilevsky, R., "Theme and variations on a string of myloid," 1989, Neurobiology of Aging, 10: 499-500.
Kisilevsky, R., "Heparan sulfate proteoglycans in amyloidogenesis: An epiphenomenon, a unique factor, or the tip of a more fundamental process?" 1990, Laboratory Investigation, 63: 589-591.
Sanes, J. R., "Extracellular matrix molecules that influence neural development," 1989, Ann. Rev. Neurosci., 12: 491-516.
Martin, G. R. et al., "Basement membrane proteins: Molecular structure and function," 1988, 39: 1-50.
McDonald, J. A., "Extracellular matrix assembly," 1988, Ann. Rev. Cell Biol., 4: 183-207.
Klier, F. G. et al., "Amyloid .beta.-protein precursor is associated with extracellular matrix," 1990, Brain Research, 515: 336-342.
Snow, A. D. et al., "Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's Syndrome," 1990, American Journal of Pathology, 137: 1253-1270.
Margolis, R. U. and R. K. Margolis, "Properties of nervous tissue proteoglycans relevant to studies on Alzheimer's disease," 1989, Neurobiology of Aging, 10: 500-502.
Caputo, C. B., "What is the significance of the binding of proteoglycans to amyloid"? 1989, Neurobiology of Aging, 10: 503-504.
Schubert, D. "The biological roles of heparan sulfate proteoglycans in the nervous system," 1989, Neurobiology of Aging, 10: 504-506.
Benditt, E. P., "What role(s) may extracellular matrix, particularly heparan sulfate, play in amyloid of Alzheimer's disease," 1989, Neurobiology of Aging, 10: 506.
Linker, A., "Proteoglycans in the pathogenesis of amyloidosis," 1989, Neurobiology of Aging, 10: 507-508.
Shirahama, T., "Proteoglycans in Amyloidogenesis," 1989, Neurobiology of Aging, 10: 508-510.
Snow, A. D. and T. N. Wight, 1989, Neurobiology of Aging, 10: 510-512.
Kisilevsky Robert
Narindrasorasak Suree
Szarek Walter A.
DeLuca Mark
Nucker Christine M.
Preston David R.
The Upjohn Company
LandOfFree
Method for identifying amyloid protein-extracellular matrix prot does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for identifying amyloid protein-extracellular matrix prot, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for identifying amyloid protein-extracellular matrix prot will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1171312